Related Experiment Videos
In vitro effect of dapsone on human chromosomes
Summary
Dapsone (DDS) at 4 mug/ml significantly increased aneuploidies and achromatic gaps in leukocyte cultures. Lower DDS concentrations did not affect metaphase rates or chromosome aberrations, suggesting a dose-dependent genotoxic effect.
Area of Science:
- Cytogenetics
- Toxicology
- Pharmacology
Background:
- Dapsone (DDS) is a sulfone medication used to treat leprosy and dermatitis herpetiformis.
- Understanding the genotoxic potential of DDS is crucial for patient safety and risk assessment.
Purpose of the Study:
- To investigate the effects of Dapsone (DDS) on chromosome aberrations in human leukocyte cultures.
- To determine if DDS induces aneuploidies and structural chromosome aberrations in a dose-dependent manner.
Main Methods:
- Human leukocyte cultures from healthy adults were treated with two different concentrations of Dapsone (DDS): 0.4 mug/ml and 4 mug/ml.
- Control cultures received no DDS treatment.
- Analysis included the proportion of accumulated metaphases, frequency of aneuploidies, and structural chromosome aberrations.
Main Results:
- Neither 0.4 mug/ml nor 4 mug/ml DDS significantly affected the rate of metaphase accumulation.
- The lower concentration (0.4 mug/ml) of DDS did not increase the frequency of chromosome aberrations.
- The higher concentration (4 mug/ml) of DDS significantly increased the proportion of aneuploidies and achromatic gaps.
Conclusions:
- Dapsone (DDS) exhibits a dose-dependent genotoxic effect on human leukocytes.
- Higher concentrations of DDS (4 mug/ml) induce significant chromosomal damage, including aneuploidies and gaps.
- These findings highlight the importance of DDS dosage in evaluating potential risks of chromosomal damage.